Cardio Share Price

Cardio Share Price

NASDAQ: CDIOW | Micro Cap | Healthcare
$0.01
+$0.01 (--%) Last updated on 07 Nov, 2026 | 00:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Cardio Stock Performance

Open
$0.01
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.01 - $0.01
Year Range
$0.01 - $0.05
Volume
2,000
Average Traded
$0.01

Cardio Share Price Chart

$0.01$0.01
L
Show Current Price
H

Cardio Stock Fundamentals & Key Indicators

Market Cap
$14711.90
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$10.00M
Return On Equity (TTM)
-113.45%
Profit Margin
-65000.00%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-17.69%

Cardio Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.01$0.00
Net Profit-$1.47-$1.79-$1.50-$1.73
Net Profit MarginN/AN/A-15000.00%N/A
Income ChangeN/A-21.77%16.20%-15.33%

Cardio Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.02$0.03$0.01
Net Profit-$4.66-$8.38-$8.38-$6.50
Net Profit MarginN/A-41900.00%-27933.33%-65000.00%
Income ChangeN/A-79.83%0.00%22.43%

Cardio Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets1.851.821.70.36
Current Assets5.928.792.775.89
Total Assets7.7710.624.466.25
Non Current Liabilities0.190.430.660.0
Current Liabilities0.60.630.841.95
Total Liabilities0.791.061.51.95
Shareholders' Equity6.979.562.964.3

Cardio Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-5.73-4.99-5.67-5.09
Investing-0.42-0.4-0.79-0.37
Financing3.4311.943.639.06

About Cardio

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Cardio Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.01
$0.01
-52.94%
Aug 2026
$0.02
$0.02
+30.77%
Jun 2026
$0.03
$0.01
+18.18%
May 2026
$0.01
$0.01
+0.00%
Apr 2026
$0.01
$0.01
-35.29%
Mar 2026
$0.02
$0.02
-62.22%
Feb 2026
$0.02
$0.04
+136.84%
Dec 2025
$0.02
$0.02
+18.75%
Aug 2025
$0.01
$0.02
+23.08%
Jul 2025
$0.01
$0.01
+0.00%
Jun 2025
$0.02
$0.01
-18.75%
May 2025
$0.04
$0.02
-56.76%

Cardio Share Price FAQs